Cambrium Bio is an innovative biotech company that specializes in the development and production of new molecular building blocks that form the basis for new materials, products, and markets. Here are the central aspects of the company:
Cambrium Bio designs, develops, and produces molecular building blocks with micromolecular precision, particularly at the level of amino acids. An outstanding example is NovaColl™, the first micromolecular and skin-identical collagen, produced through a precise fermentation process rather than being extracted from animal sources[2].
The process involves several steps:
The mission of Cambrium Bio is to create a new generation of sustainable materials to combat the ecological crisis caused by conventional materials. The company aims to develop products that are better for both people and the environment. By applying molecular design technology, a "Cambrian explosion" of bio-based materials is sought, transforming everyday products in various applications such as personal care products and packaging[1][2].
Cambrium Bio is committed to shaping a sustainable future by moving away from conventional material sources such as oil wells, mines, and slaughterhouses. By using yeast in fermentation and precise purification technology, it ensures that production is environmentally friendly and sustainable. The company recently received 8 million euros to advance the transition to a bio-based economy with molecular design technology[5].
Mitchell Duffy, a PhD biotechnologist, is the CEO of Cambrium and co-founded the company with Dr. Charlie Cotton. The company was recently awarded "Deep Tech Star 2024" in the category of "Artificial Intelligence"[3][4].
Cambrium Bio is thus a pioneer in the development of innovative, sustainable materials that not only protect the environment but also open up new opportunities for industry.